Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2010-08-23 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
2010年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2010 年半年度报告" which translates to "2010 Semi-Annual Report". It contains detailed financial data, including main financial indicators, profit and loss figures, cash flow, shareholder information, management changes, board reports, investment and asset transactions, legal proceedings, and governance information. The report covers a half-year period (January to June 2010) and includes unaudited financial statements. The length is substantial (15,000 characters), and the content is comprehensive, not merely an announcement or certification. This matches the definition of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements and substantive financial data and analysis. Therefore, the document should be classified as an Interim / Quarterly Report (IR). H1 2010
2010-08-23 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a public announcement regarding abnormal stock price fluctuations over three consecutive trading days. It includes statements from the company's board confirming no undisclosed material information or major asset restructuring plans that could affect stock price. The document is short (681 characters) and serves as a regulatory disclosure about stock trading activity and risk warning to investors. It does not contain financial statements, management discussion, or detailed report content. It fits the category of a general regulatory announcement about stock trading and company disclosures, which aligns with Regulatory Filings (RNS).
2010-07-01 Chinese
2009年年度股东大会法律意见书
AGM Information Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding the 2009 Annual General Meeting (AGM) of the company. It details the legality and compliance of the AGM's convening, attendance, voting procedures, and results. It references the 2009 Annual Report and other related reports but does not contain the reports themselves. The document is not the Annual Report (10-K) but a legal opinion on the AGM proceedings. Therefore, it fits the category of AGM Information (AGM-R), which includes materials shared during the AGM such as legal opinions on the meeting.
2010-06-26 Chinese
2009年度股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is titled as a "2009年度股东大会决议公告" which translates to "2009 Annual General Meeting Resolution Announcement." It details the resolutions passed at the 2009 Annual General Meeting (AGM) of the company, including voting results on various agenda items such as the annual report, board work report, financial statements, profit distribution, and amendments to company rules. The document also mentions the meeting date, attendance, and legal opinion on the meeting's validity. The content is focused on announcing the voting results and resolutions from the AGM rather than presenting the full annual report or financial statements themselves. The document length is 2520 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2010-06-26 Chinese
2009年度股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as materials for the 2009 Annual General Meeting (AGM) of the company 中源协和干细胞生物工程股份公司, dated June 18, 2010, with the meeting scheduled for June 25, 2010. It contains the agenda, meeting rules, and multiple proposals for shareholder voting, including approval of the 2009 annual report, board and supervisory reports, financial statements, profit distribution, and amendments to company bylaws and governance rules. The document is clearly a set of materials prepared for and presented at the AGM, including detailed agenda and proposals for shareholder consideration and voting. It is not the annual report itself, nor a voting results announcement, but the information and materials shared during the AGM. The document length (5602 characters) supports it being a full AGM information document rather than a brief announcement. Therefore, the appropriate classification is AGM Information (AGM-R).
2010-06-18 Chinese
控股子公司财务管理办法（2010年6月）
Governance Information Classification · 95% confidence The document is a detailed internal policy manual titled '控股子公司财务管理办法' (Financial Management Measures for Controlling Subsidiaries) issued by a company. It outlines principles, responsibilities, procedures, and controls related to financial management of subsidiaries, including budgeting, reporting, auditing, and financial supervision. It does not contain financial statements, earnings data, or regulatory disclosures. It is not an announcement or a brief summary but a comprehensive internal governance document related to financial management practices. This fits best under Governance Information (CGR), which covers reports detailing internal rules, board structure, and governance practices. The document length is 4138 characters, which is sufficient for a detailed governance policy but too short and not appropriate for an Annual Report or Interim Report. There is no indication of it being a certification, announcement, or legal proceeding. Therefore, the classification is CGR with high confidence.
2010-06-05 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.